Material analysis conducted by the Leading Global Fumed Silica Manufacturer (LGFSM) confirmed several notable improvements in the fumed silica produced during Phase 1 Test #5 compared to Test #4: With ...
Gilead Sciences has chosen a partner for lenacapavir in the race to develop new low-frequency treatments for HIV. After comparing two phase 1 integrase strand transfer inhibitors, the Bay Area pharma ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results